Henry Schein, Inc. (NASDAQ:HSIC) – Research analysts at William Blair lifted their Q1 2018 EPS estimates for shares of Henry Schein in a report issued on Wednesday. William Blair analyst J. Kreger now forecasts that the company will earn $0.92 per share for the quarter, up from their prior estimate of $0.90. William Blair also issued estimates for Henry Schein’s Q2 2018 earnings at $0.92 EPS, Q4 2018 earnings at $1.17 EPS, FY2018 earnings at $4.15 EPS, FY2019 earnings at $4.57 EPS and FY2020 earnings at $5.03 EPS.

HSIC has been the topic of a number of other research reports. Zacks Investment Research raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, January 4th. Royal Bank of Canada reduced their price target on Henry Schein from $91.00 to $82.00 and set a “sector perform” rating on the stock in a research report on Tuesday, November 7th. Jefferies Group reissued a “hold” rating and set a $89.00 price target on shares of Henry Schein in a research report on Friday, October 20th. Stephens began coverage on Henry Schein in a research report on Tuesday, November 28th. They set an “equal weight” rating and a $76.00 price target on the stock. Finally, Morgan Stanley downgraded Henry Schein from an “equal weight” rating to an “underweight” rating and set a $88.00 price target on the stock. in a research report on Wednesday, December 6th. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $84.23.

Shares of Henry Schein (NASDAQ:HSIC) traded up $1.20 during trading hours on Monday, reaching $76.04. The company had a trading volume of 2,075,600 shares, compared to its average volume of 1,374,020. The firm has a market capitalization of $11,990.00, a P/E ratio of 21.91, a P/E/G ratio of 1.91 and a beta of 0.99. Henry Schein has a 1-year low of $65.28 and a 1-year high of $93.50. The company has a quick ratio of 0.86, a current ratio of 1.55 and a debt-to-equity ratio of 0.30.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Monday, November 6th. The company reported $0.87 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.90 by ($0.03). The company had revenue of $3.16 billion for the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The company’s quarterly revenue was up 10.3% compared to the same quarter last year. During the same period in the prior year, the company earned $0.84 EPS.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. National Pension Service boosted its holdings in shares of Henry Schein by 8.3% during the 4th quarter. National Pension Service now owns 176,655 shares of the company’s stock valued at $12,345,000 after acquiring an additional 13,612 shares in the last quarter. Bank of Montreal Can boosted its holdings in shares of Henry Schein by 10.8% during the 4th quarter. Bank of Montreal Can now owns 393,655 shares of the company’s stock valued at $27,509,000 after acquiring an additional 38,249 shares in the last quarter. Addenda Capital Inc. acquired a new stake in shares of Henry Schein during the 4th quarter valued at $410,000. DnB Asset Management AS boosted its holdings in shares of Henry Schein by 283.6% during the 4th quarter. DnB Asset Management AS now owns 94,006 shares of the company’s stock valued at $6,569,000 after acquiring an additional 69,500 shares in the last quarter. Finally, Aurora Investment Counsel acquired a new stake in shares of Henry Schein during the 4th quarter valued at $1,580,000. 91.70% of the stock is currently owned by institutional investors.

In related news, Director Barry J. Alperin sold 5,796 shares of the firm’s stock in a transaction on Friday, December 1st. The stock was sold at an average price of $70.76, for a total transaction of $410,124.96. Following the sale, the director now owns 48,172 shares of the company’s stock, valued at approximately $3,408,650.72. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 1.19% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Analysts Issue Forecasts for Henry Schein, Inc.’s Q1 2018 Earnings (HSIC)” was first posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this story on another publication, it was stolen and reposted in violation of United States and international copyright legislation. The correct version of this story can be accessed at https://theolympiareport.com/2018/01/17/analysts-issue-forecasts-for-henry-schein-inc-s-q1-2018-earnings-hsic.html.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.